The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to ...
Interesting Engineering on MSN
China’s neighbor tests 2-layer ballistic missile defense shield for nuclear threats
India’s Defence Research and Development Organisation (DRDO) has completed three back-to-back flight tests of ...
17don MSN
DRDO successfully conducts 3rd multi-layered ballistic missile defence capability flight test
The Defence Research and Development Organisation (DRDO) successfully completed three consecutive development flight trials ...
The following is the June 23, 2026, Congressional Research Service In Focus report, The Terminal High Altitude Area Defense ...
Rhemy Hinckesman has been rewarded for her rapid rise through the ranks, earning a place in the Broncos’ NRLW Top 24 squad ...
The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo® reported for the first time as ...
The United States on Wednesday released the official text of the memorandum of understanding reached over the weekend with ...
Five Sunshine Coast school rugby league players have reached the glowing heights of Queensland representation after their ...
At the big endocrinology meetings this season, one story kept stealing the room: the pill that turned an injectable blockbuster into the fastest-moving launch in modern pharma. Novo Nordisk’s oral ...
GlycoNex, Inc. (4168, hereinafter referred to as GNX), today announced that the Phase III clinical trial for SPD8, a Denosumab biosimilar co-developed with Mitsubishi Gas Chemical, ...
We are proud to announce BMD Group as our new Indigenous Engagement Partner, supporting the delivery of the AFLNT Women and Girls Education Program. As part of the partnership, BMD will support the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results